Skip to content

Characteristics of Subjects With Overweight or Obesity at the Onset of Hypertension

Characteristics of Subjects With Overweight or Obesity at the Onset of Hypertension

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04093947
Enrollment
100
Registered
2019-09-18
Start date
2019-10-01
Completion date
2020-10-01
Last updated
2019-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension, Obesity

Brief summary

The study aims to investigate the characteristics of subjects with hypertension at onset among a cohort of apparently healthy subjects, with overweight or obesity (BMI ≥ 25 Kg / m2), and free of any drug treatment at the baseline. The evaluation includes anthropometric (weight, height, BMI, waist circumference), haematochemical (hormones, metabolic and routine) parameters and the screening for hypertension with ABPM. The diagnosis of hypertension is made in accordance with the 2017 guidelines of the American College of Cardiology / American Heart Association ACC / AHA.

Interventions

OTHERObservational study

Observational and prospective study

Sponsors

Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
35 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

* Overweight or obesity (BMI\> 25 Kg/m2)

Exclusion criteria

* Any kind of drug * Hypertension * Endocrine diseases (diabetes mellitus, hypo or hyperthyroidism, hypopituitarism, etc.), * Chronic inflammatory diseases * Renal failure * Liver failure * Angina pectoris * Myocardial infarction and heart failure * Genetic heart diseases * Thrombocytopenias

Design outcomes

Primary

MeasureTime frameDescription
Total cholesterolAt baselineTotal cholesterol (mg/dL) concentrations in serum
eGFR (estimated glomerular filtration rate)At baselineeGFR (ml/min/1.73 mq)
CreatininAt baselineCreatinin (mg/dl) concentration in serum
Uric acidAt baselineUric acid (mg/dL) concentration in serum
Thyroid hormones (FT3, FT4)At baselineFT3 (pg/mL), FT4 (pg/mL) concentration in serum
HDL cholesterolAt baselineHDL cholesterol (mg/dL) concentrations in serum
LDL cholesterolAt baselineLDL cholesterol (mg/dL) concentrations in serum
TriglyceridesAt baselineTriglycerides (mg/dL) concentrations in serum
TSHAt baselineTSH (mU/L) concentration in serum
InsulinAt baselineInsulin (mIU/L) concentration in serum
PotassiumAt baselinePotassium (mmol/L) concentration in serum
SodiumAt baselineSodium (mEq/L) concentration in serum

Secondary

MeasureTime frameDescription
HeightAt baselineHeight in meters
WeightAt baselineWeight in kilograms
BMIAt baselineBMI (kg/m\^2)

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026